Skip to search formSkip to main contentSkip to account menu

azilsartan medoxomil 40 MG Oral Tablet [Edarbi]

Known as: Azilsartan kamedoxomil 40 mg ORAL TABLET [Edarbi], Edarbi 40 MG (azilsartan kamedoxomil 42.68 MG) Oral Tablet, Edarbi 40 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

12 relations
Azilsartan kamedoxomilCroscarmellose SodiumEdarbiFumaric acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study
Objective: To evaluate azilsartan medoxomil (AZM) (Edarbi®) utilization patterns in the primary-care setting in Germany… 
2017
2017
Возможности комбинации азилсартана медоксомила и хлорталидона: можно ли бороться с артериальной гипертонией и ожирением одновременно?
Arterial hypertension (AH) and obesity are the main risk factors of chronic noncommunicable diseases. Adipous tissue is not only… 
Review
2012
Review
2012
Azilsartan medoxomil: a review of its use in hypertension.
Azilsartan medoxomil (Edarbi®; Ipreziv™) is an orally administered angiotensin II receptor type 1 antagonist (blocker) used in… 
2011
2011
Azilsartan medoxomil (Edarbi) the eighth ARB.
The angiotensin receptor blocker (ARB) azilsartan medoxomil (Edarbi-Takeda) was recently approved by the FDA for oral treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)